IRIS
Armenia, Daniele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 474
SA - Sud America 257
EU - Europa 241
NA - Nord America 206
AF - Africa 21
Totale 1.199
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 231
IT - Italia 192
US - Stati Uniti d'America 185
SG - Singapore 176
CN - Cina 110
VN - Vietnam 61
HK - Hong Kong 57
GB - Regno Unito 23
BD - Bangladesh 17
ID - Indonesia 12
MX - Messico 11
AR - Argentina 10
IN - India 8
TR - Turchia 8
EC - Ecuador 7
ZA - Sudafrica 6
DE - Germania 5
PK - Pakistan 5
UA - Ucraina 5
IQ - Iraq 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CM - Camerun 3
NL - Olanda 3
NP - Nepal 3
SA - Arabia Saudita 3
VE - Venezuela 3
CA - Canada 2
CL - Cile 2
FR - Francia 2
JM - Giamaica 2
KE - Kenya 2
NI - Nicaragua 2
OM - Oman 2
PE - Perù 2
PL - Polonia 2
PY - Paraguay 2
RU - Federazione Russa 2
TN - Tunisia 2
AM - Armenia 1
BB - Barbados 1
BE - Belgio 1
BF - Burkina Faso 1
BY - Bielorussia 1
CG - Congo 1
EG - Egitto 1
ET - Etiopia 1
FI - Finlandia 1
GT - Guatemala 1
HN - Honduras 1
KR - Corea 1
MA - Marocco 1
MY - Malesia 1
MZ - Mozambico 1
NA - Namibia 1
PR - Porto Rico 1
RE - Reunion 1
SI - Slovenia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 1.199
Salva come PNG Salva come JPEG
Città #
Rome 181
Singapore 104
Beijing 67
Hong Kong 53
Santa Clara 50
Ho Chi Minh City 29
Ashburn 18
Hanoi 17
São Paulo 16
Rio de Janeiro 14
Belo Horizonte 9
Baltimore 8
Oxford 8
Bicester 7
Secaucus 7
Buffalo 6
Dallas 6
Dhaka 6
Mexico City 6
Brasília 5
Curitiba 5
Joinville 5
Bari 4
Goiânia 4
Miami 4
Quito 4
Bagé 3
Ipatinga 3
Juiz de Fora 3
Salvador 3
São Gonçalo 3
Volta Redonda 3
Abu Dhabi 2
Antakya 2
Boa Vista 2
Cabo Frio 2
Cambé 2
Campinas 2
Can Tho 2
Caxias do Sul 2
Da Nang 2
Erbil 2
Indaiatuba 2
Itabira 2
Johannesburg 2
João Pessoa 2
Kingston 2
Lahore 2
Latisana 2
Los Angeles 2
Maceió 2
Managua 2
Manaus 2
Mogi das Cruzes 2
Mount Vernon 2
Muscat 2
Ourinhos 2
Porto Alegre 2
Ribeira do Pombal 2
Santa Maria 2
Santiago 2
Sete Lagoas 2
São José dos Campos 2
São João del Rei 2
Ta'if 2
Viçosa 2
Xi'an 2
Addis Ababa 1
Ajman 1
Almenara 1
Altinordu 1
Anchorage 1
Andorinha 1
Anniston 1
Anápolis 1
Aparecida de Goiânia 1
Aquidabã 1
Aquiraz 1
Aracaju 1
Araçoiaba da Serra 1
Ariquemes 1
Arlington Heights 1
Assaré 1
Assis 1
Asunción 1
Babahoyo 1
Baghdad 1
Barra Mansa 1
Basra 1
Bauru 1
Belford Roxo 1
Berat 1
Berkeley 1
Bismarque 1
Bluffton 1
Blumenau 1
Blyth 1
Bossier City 1
Botucatu 1
Bridgetown 1
Totale 764
Salva come PNG Salva come JPEG
Nome #
Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in Italy 69
Confirmed virological failure following enhanced adherence counseling among virally unsuppressed children and adolescents on dolutegravir-based versus other regimens: Evidence from a cohort analysis in Cameroon 41
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21 40
Impact of baseline HIV-1 integrase polymorphisms on virological outcome in a large European cohort of patients starting a raltegravir-containing regimen 30
Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals 28
Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings 28
Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES study 23
Clinical relevance of next generation sequencing on baseline detection of minority resistance associated variants in HCV-1 patients treated with protease inhibitors 23
CMV seroprevalence and coronary CMV-DNA detection in immunocompetent patients with heart diseases 23
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice 22
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings 21
A Very Low Geno2pheno False Positive Rate Is Associated with Poor Viro-Immunological Response in Drug-Naive Patients Starting a First-Line HAART 21
Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease 20
Impact of HIV-1 subtypes and integrase natural polymorphisms on virological response to first-line integrase inhibitors based regimens 20
Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients 19
Emerging patterns and implications of HIV-1 integrase inhibitor resistance 19
A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection 19
BASELINE/EARLY PRESENCE OF KNOWN AND NOVEL RESISTANCE MUTATIONS IS ASSOCIATED WITH VIRAL FAILURE IN DIFFICULT-TO-TREAT PATIENTS TREATED WITH FIRST GENERATION PROTEASE INHIBITORS 19
HIV MDR is still a relevant issue despite its dramatic drop over the years 19
Darunavir (DRV)/r plus raltegravir (RAL) dual regimen in multi-experienced population: long term efficacy and tolerability 19
Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells 18
Hepatitis B Surface Antigen Genetic Elements Critical for Immune Escape Correlate With Hepatitis B Virus Reactivation Upon Immunosuppression 18
A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of Italy 18
A high HBsAg genetic complexity can influence HBV immunogenicity in the setting of acute infection 17
P681 HBsAg MUTATIONS WITH ENHANCED CAPABILITY TO EVADE IMMUNE RESPONSE ARE ASSOCIATED WITH HBV REACTIVATION DURING IMMUNOSUPPRESSION 17
Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings 17
Does ultra-deep-sequencing in HCV patients treated with boceprevir/telaprevir-based therapy provide an added value in comparison to standard population-sequencing in the detection of resistance? 16
Anti-HIV-1 activity of new integrase inhibitors in lymphocytes and human primary macrophages 16
Focus on recently developed assays for detection of resistance/sensitivity to reverse transcriptase inhibitors 16
P696 A COMPLEX HBV QUASISPECIES IN RT AND HBsAg CHARACTERIZES PATIENTS WITH ACUTE HEPATITIS B: A REFINED UDPS ANALYSIS 15
Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA 15
Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy 15
Virological response and resistance in multi-experienced patients treated with raltegravir 15
Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practice 15
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 15
PRESTIGIO RING: "A 28-year-old highly treatmentexperienced man with vertical HIV infection on ibalizumab therapy: ART simplification perspectives" 14
Secondary Integrase Resistance Mutations Found in HIV-1 Minority Quasispecies in Integrase Therapy-Naive Patients Have Little or No Effect on Susceptibility to Integrase Inhibitors 14
Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage 14
IMPACT OF MUTATIONS AT POSITION 135 OF HIV-1 REVERSE TRANSCRIPTASE ON VIROLOGIC RESPONSE TO A FIRST LINE NNRTI-CONTAINING HAART 14
Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study 14
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV 14
Natural raltegravir-resistance is a rare event in integrase-inhibitors naive patients, and when present, is confined to a restricted minority of secondary variants and is not associated with virological response to raltegravir 14
High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries 14
Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment. 14
The Genotypic False Positive Rate Determined by V3 Population Sequencing Can Predict the Burden of HIV-1 CXCR4-using Species Detected by Pyrosequencing 14
Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals 14
HBsAg genetic elements critical for immune escape correlates with HBV reactivation upon immunosuppression 14
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 13
Selection and coevolution of mutational patterns in the HIV-1 integrase characterized by pyrosequencing analysis 13
Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database 13
Study of Genotypic and Phenotypic HIV-1 Dynamics of Integrase Mutations During Raltegravir Treatment: A Refined Analysis by Ultra-Deep 454 Pyrosequencing 13
Identification of a rare mutation at reverse transcriptase Lys65 (K65E) in HIV-1-infected patients failing on nucleos(t)ide reverse transcriptase inhibitors 12
The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patients 12
P0580 : Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome 12
HIV-1 INTEGRASE MUTATIONS, FOUND AS MINORITY QUASISPECIES IN PATIENTS NAIVE TO INTEGRASE INHIBITORS, ARE ASSOCIATED WITH DECREASED SUSCEPTIBILITY TO RALTEGRAVIR AND ELVITEGRAVIR IN VITRO 12
HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBVcoinfected patients on first-line therapy 12
Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs in Combination with the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- and Middle-Income Countries 12
Very high pre-therapy viral load is a predictor of virological rebound in HIV-1-infected patients starting a modern first-line regimen. 12
Impact of pre-therapy viral load on virological response to modern first-line HAART 12
HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia 11
The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype 11
Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers 11
Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens 11
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice 11
P0915 : Clinical relevance of baseline/early detection and persistence of resistant associated variants in HCV-1 patients treated with protease-inhibitors assessed by ultra-deep sequencing 11
Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice 10
Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients 10
THE LOWEST X4 GENO2PHENO-FALSE POSITIVE RATE IS ASSOCIATED WITH GREATER CD4-DEPLETION 10
Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children. 10
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro. 10
Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation 9
Role of low-frequency integrase strand transfer inhibitor resistance mutations on virological outcomes in antiretroviral therapy-naïve individuals initiating second-generation integrase inhibitors 9
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B 9
Reliability and Clinical Relevance of the HIV-1 Drug Resistance Test in Patients With Low Viremia Levels 8
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen 8
Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice 7
Totale 1.248
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20242 0 0 0 0 0 0 0 0 0 0 0 2
2024/2025826 55 0 12 104 17 11 101 97 45 28 176 180
2025/2026420 118 10 151 127 14 0 0 0 0 0 0 0
Totale 1.248